- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Transformed B-Cell Non-Hodgkin Lymphoma in New Zealand
Total 1437 results
-
TG Therapeutics, Inc.CompletedWaldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Non Follicular Indolent Non-Hodgkin LymphomaUnited States
-
Hoffmann-La RocheAbbVieCompletedLymphoma, Non-HodgkinSpain, Hungary, United States, Canada, Australia, Austria, Czechia, France, Italy, Netherlands
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbTerminatedDiffuse Large B-cell LymphomaUnited States
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
ADC Therapeutics S.A.CompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | Burkitt's Lymphoma | Lymphoma, Marginal ZoneUnited Kingdom, United States, Italy
-
Weill Medical College of Cornell UniversityCompletedDiffuse Large B-cell LymphomaUnited States
-
AmgenCompletedLymphoma | Leukemia | Cancer | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Hematologic Malignancies | Diffuse Large Cell Lymphoma | Oncology | Tumors | T Cell Lymphoma | Oncology Patients | Hematology | Low Grade LymphomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Denmark, Italy, France, Australia, United Kingdom
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia (ALL) | Diffuse Large B-Cell Lymphoma (DLBCL)United States
-
Weill Medical College of Cornell UniversityCelgeneCompletedDiffuse Large B Cell LymphomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneBristol-Myers SquibbCompletedNeoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Immune System DisorderUnited States
-
Aegera TherapeuticsThe Leukemia and Lymphoma SocietyTerminatedLymphoma, B-Cell | Leukemia, Lymphocytic, Chronic, B-CellCanada, United States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Xynomic Pharmaceuticals, Inc.Active, not recruitingMantle Cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
Bristol-Myers SquibbCompletedRenal Cell Carcinoma | Non-hodgkin's LymphomaUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; Genentech, Inc.RecruitingLymphoma, Non-Hodgkin | Follicular Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
Pharmacyclics LLC.CompletedDiffuse Large Cell B-lymphomaUnited States
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
University of RochesterRecruiting
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; American Society of Clinical Oncology; Applebaum FoundationRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Novartis PharmaceuticalsCompletedLymphoma | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic LymphomaUnited States, Puerto Rico
-
Hackensack Meridian HealthCelgene CorporationCompletedDiffuse Large B Cell LymphomaUnited States
-
Sutro Biopharma, Inc.Active, not recruitingFollicular Lymphoma | B-cell Lymphoma | Multiple Myeloma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Indolent Lymphoma | B Cells--TumorsUnited States
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
MorphoSys AGIqvia Pty LtdRecruitingDiffuse Large B-cell LymphomaUnited States
-
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)RecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | MALT Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Indolent Lymphoma | Refractory B-Cell LymphomaUnited States, Australia, China
-
Zhejiang DTRM BiopharmaCompletedChronic Lymphocytic Leukemia | B-Cell LymphomaUnited States
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingDLBCL | Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States
-
Millennium Pharmaceuticals, Inc.CompletedNon-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell LymphomaUnited States
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
Joshua BrodyCelldex TherapeuticsCompletedLow-Grade B-cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedTransformed Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Burkitt's LymphomaUnited States, Spain, Italy, United Kingdom
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
Pharmacyclics LLC.CompletedB-Cell Leukemia | B-Cell LymphomaUnited States
-
ADC Therapeutics S.A.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell LymphomaSpain, United States